GleamWall
中文EN

CHUC Charlie's Holdings, Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1134765 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY266.1%
TTM net income YoY-222.5%
TTM EPS YoY-171.4%
Revenue 3-yr CAGR9.2%
Net income 3-yr CAGR—

Margins

Gross margin27.4%
Operating margin-10.8%
Net margin-7.9%
FCF margin—
EBITDA margin-10.7%

Returns

ROE-73.5%
ROA-20.9%
ROIC (approx.)-126.2%
Asset turnover2.63x

Leverage & solvency

Liabilities / assets75.5%
Debt / equity0.00x
Current ratio1.65x
Interest coverage-9.86x

Cash quality & payout

Operating cash flow / net income2.15x
Accruals ratio23.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
Income statement
Revenue$3.80M$4.80M$8.98M$7.08M$1.76M$1.58M$1.78M$1.62M
Cost of revenue$2.68M$3.62M$6.28M$5.32M$1.27M$1.19M$522,000$994,000
Gross profit$1.12M$1.18M$2.70M$1.76M$486,000$386,000$525,000$630,000
SG&A expense$1.92M$1.74M$2.14M$1.69M$1.36M$1.09M$1.33M$1.42M
Operating income-$1.23M-$975,000-$123,000-$339,000-$954,000-$879,000-$899,000-$876,000
Interest expense$81,000$75,000$78,000$37,000$333,000$241,000$226,000$146,000
Pretax income-$1.66M-$1.05M-$201,000$624,000$5.31M-$1.27M-$969,000-$1.02M
Income tax$0$0-$151,000$0$388,000$0$0$0
Net income-$1.66M-$1.05M$131,000$624,000$4.96M-$1.22M-$1.12M-$1.02M
EBITDA-$1.23M-$969,000-$117,000-$331,000-$942,000-$866,000-$885,000-$852,000
EPS (basic)-0.010.00—0.000.02-0.01—0.00
EPS (diluted)———0.000.000.00—0.00
Weighted avg. shares (diluted)274.07M268.13M—277.56M281.98M253.57M—242.57M
Balance sheet
Cash & equivalents$527,000$640,000$1.32M$1.15M$1.45M$112,000$211,000$601,000
Receivables$452,000$1.27M$440,000$1.15M$379,000$17,000$331,000$84,000
Inventory$9.07M$10.10M$6.72M$4.25M$3.62M$2.63M$2.13M$2.73M
Current assets$11.99M$14.12M$10.77M$9.84M$5.85M$3.00M$3.72M$3.94M
PP&E, net$173,000$31,000$37,000$20,000$20,000$40,000$53,000$67,000
Total assets$12.79M$14.85M$11.56M$10.56M$5.97M$3.17M$3.94M$4.22M
Current liabilities$7.24M$9.27M$7.63M$6.76M$3.63M$5.83M$5.58M$5.33M
Long-term debt—————$3.14M$2.16M$2.57M
Total debt—————$3.14M$2.16M$2.57M
Total liabilities$9.66M$11.74M$8.14M$7.32M$3.79M$5.98M$5.72M$5.48M
Shareholders' equity$3.13M$3.11M$3.42M$3.24M$2.19M-$2.81M-$1.78M-$1.26M
Net debt—————$3.02M$1.95M$1.97M
Shares outstanding280.55M274.20M270.65M270.57M259.95M257.41M257.29M249.57M
Cash flow statement
Operating cash flow-$383,000-$1.10M$394,000-$3.11M-$2.65M-$409,000-$377,000-$944,000
Investing cash flow——-$23,000$1.00M——$0$0
Financing cash flow$270,000$425,000-$201,000$1.81M-$2.50M$310,000-$13,000$460,000
Depreciation & amortization$5,000$6,000$6,000$8,000$12,000$13,000$14,000$24,000
Stock-based compensation$18,000$25,000$53,000$55,000$38,000$40,000$57,000$56,000

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.